Matches in SemOpenAlex for { <https://semopenalex.org/work/W1986268755> ?p ?o ?g. }
- W1986268755 endingPage "168" @default.
- W1986268755 startingPage "161" @default.
- W1986268755 abstract "Abstract Copy number changes in TOP2A have frequently been linked to ERBB2 (HER2) amplified breast cancers. To study this relationship, copy number changes of ERBB2 and TOP2A were investigated by fluorescence in situ hybridization (FISH) in two cell lines; one characterized by having amplification of both genes and the other by having amplification of ERBB2 and deletion of TOP2A. The characteristics are compared to findings on paired ERBB2 and TOP2A data from 649 patients with invasive breast cancer from a previously published biomarker study. The physical localization of FISH signals in metaphase spreads from cell lines showed that simultaneous amplification is not a simple co‐amplification of a whole amplicon containing both genes. Most gene signals are translocated to abnormal marker chromosomes. ERBB2 genes but not TOP2A genes are present in tandem amplicons, leading to a higher ERBB2 ratio. This observation was confirmed by patient FISH data: among 276 (43% of all patients) abnormal tumors, 67% had different ERBB2 and TOP2A status. ERBB2 amplification with normal TOP2A status was found in 36% of the abnormal tumors (15% of all patients). Simultaneous amplification of both genes was found in 28% of the abnormal tumors (12% of all patients) while TOP2A deletion and ERBB2 amplification was observed in 16% of the abnormal cases (8% of all patients). A small number of tumors had TOP2A amplification (4%) or deletion (6%) without simultaneous changes of the ERBB2 gene. ERBB2 deletion was also observed (5%) but only in tumors with simultaneous TOP2A deletion. The average gene/reference ratio was significantly different: 5.0 for TOP2A but 7.2 for ERBB2 in the amplified tumors (P<0.01). Amplification of the two genes may be caused by different mechanisms, leading to higher level of amplification for ERBB2 compared to TOP2A. In the majority of breast cancer patients, simultaneous aberration of ERBB2 and TOP2A is not explained by simple co‐amplification." @default.
- W1986268755 created "2016-06-24" @default.
- W1986268755 creator A5009675722 @default.
- W1986268755 creator A5013130361 @default.
- W1986268755 creator A5015859540 @default.
- W1986268755 creator A5019620262 @default.
- W1986268755 creator A5031500387 @default.
- W1986268755 creator A5034630560 @default.
- W1986268755 creator A5062998904 @default.
- W1986268755 date "2009-11-18" @default.
- W1986268755 modified "2023-10-18" @default.
- W1986268755 title "Aberrations of<i>ERBB2</i>and<i>TOP2A</i>genes in breast cancer" @default.
- W1986268755 cites W1829553711 @default.
- W1986268755 cites W1978331365 @default.
- W1986268755 cites W1981776102 @default.
- W1986268755 cites W1999919183 @default.
- W1986268755 cites W2001624468 @default.
- W1986268755 cites W2005265464 @default.
- W1986268755 cites W2018093390 @default.
- W1986268755 cites W2030796899 @default.
- W1986268755 cites W2046162893 @default.
- W1986268755 cites W2048191924 @default.
- W1986268755 cites W2056065886 @default.
- W1986268755 cites W2058598914 @default.
- W1986268755 cites W2060084956 @default.
- W1986268755 cites W2062083469 @default.
- W1986268755 cites W2064941857 @default.
- W1986268755 cites W2073009876 @default.
- W1986268755 cites W2073101093 @default.
- W1986268755 cites W2074573190 @default.
- W1986268755 cites W2078038998 @default.
- W1986268755 cites W2081949650 @default.
- W1986268755 cites W2095326628 @default.
- W1986268755 cites W2096471659 @default.
- W1986268755 cites W2096910745 @default.
- W1986268755 cites W2099112662 @default.
- W1986268755 cites W2099380770 @default.
- W1986268755 cites W2102511280 @default.
- W1986268755 cites W2113164860 @default.
- W1986268755 cites W2115579297 @default.
- W1986268755 cites W2119416636 @default.
- W1986268755 cites W2120584854 @default.
- W1986268755 cites W2130900820 @default.
- W1986268755 cites W2164976222 @default.
- W1986268755 cites W2167841373 @default.
- W1986268755 cites W4322716809 @default.
- W1986268755 doi "https://doi.org/10.1016/j.molonc.2009.11.001" @default.
- W1986268755 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5527893" @default.
- W1986268755 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19945923" @default.
- W1986268755 hasPublicationYear "2009" @default.
- W1986268755 type Work @default.
- W1986268755 sameAs 1986268755 @default.
- W1986268755 citedByCount "29" @default.
- W1986268755 countsByYear W19862687552012 @default.
- W1986268755 countsByYear W19862687552013 @default.
- W1986268755 countsByYear W19862687552014 @default.
- W1986268755 countsByYear W19862687552015 @default.
- W1986268755 countsByYear W19862687552016 @default.
- W1986268755 countsByYear W19862687552017 @default.
- W1986268755 countsByYear W19862687552019 @default.
- W1986268755 countsByYear W19862687552020 @default.
- W1986268755 countsByYear W19862687552021 @default.
- W1986268755 countsByYear W19862687552022 @default.
- W1986268755 crossrefType "journal-article" @default.
- W1986268755 hasAuthorship W1986268755A5009675722 @default.
- W1986268755 hasAuthorship W1986268755A5013130361 @default.
- W1986268755 hasAuthorship W1986268755A5015859540 @default.
- W1986268755 hasAuthorship W1986268755A5019620262 @default.
- W1986268755 hasAuthorship W1986268755A5031500387 @default.
- W1986268755 hasAuthorship W1986268755A5034630560 @default.
- W1986268755 hasAuthorship W1986268755A5062998904 @default.
- W1986268755 hasBestOaLocation W19862687551 @default.
- W1986268755 hasConcept C104317684 @default.
- W1986268755 hasConcept C120599132 @default.
- W1986268755 hasConcept C120821319 @default.
- W1986268755 hasConcept C121608353 @default.
- W1986268755 hasConcept C141231307 @default.
- W1986268755 hasConcept C150194340 @default.
- W1986268755 hasConcept C153911025 @default.
- W1986268755 hasConcept C2777542201 @default.
- W1986268755 hasConcept C2781197716 @default.
- W1986268755 hasConcept C30481170 @default.
- W1986268755 hasConcept C36823959 @default.
- W1986268755 hasConcept C49105822 @default.
- W1986268755 hasConcept C502942594 @default.
- W1986268755 hasConcept C530470458 @default.
- W1986268755 hasConcept C54355233 @default.
- W1986268755 hasConcept C55548728 @default.
- W1986268755 hasConcept C70278784 @default.
- W1986268755 hasConcept C7602840 @default.
- W1986268755 hasConcept C8185291 @default.
- W1986268755 hasConcept C86803240 @default.
- W1986268755 hasConceptScore W1986268755C104317684 @default.
- W1986268755 hasConceptScore W1986268755C120599132 @default.
- W1986268755 hasConceptScore W1986268755C120821319 @default.
- W1986268755 hasConceptScore W1986268755C121608353 @default.
- W1986268755 hasConceptScore W1986268755C141231307 @default.
- W1986268755 hasConceptScore W1986268755C150194340 @default.